At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 131 enrolled
Drug / intervention
Baclofen, Diazepam, Clonazepam, Trihexyphenidyl, Tetrabenazine, Gabapentin, Topiramate, Lamotrigine, Amitriptyline. +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Excessive Crying in Children With Cerebral Palsy and Communication Deficits -a Fixed-sequence, Crossover Clinical Trial
In Brief
A Phase 4 clinical trial evaluating Placebo and Baclofen, Diazepam, Clonazepam, Trihexyphenidyl, Tetrabenazine, Gabapentin, Topiramate, Lamotrigine, Amitriptyline. for Cerebral Palsy and 2 related conditions. Completed, enrolled 131 participants.
Detailed Summary
Management of excessive crying in children with cerebral palsy and communication deficits \[ECCCPCD\] was guided by the associated clinical findings and investigations.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebral Palsy, Excessive Crying, Pain
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2005
Primary CompletionAug 2020
First PostedAug 2020
TodayJul 2026
First PostedAug 24, 2020
Enrollment StartDec 7, 2005
Primary CompletionAug 4, 2020
TodayJul 2, 2026
Enrollment to primary: 14.7 yearsPosted 5.9 years ago
Interventions
Placeboother
Fructose powder identical with the drugs was used
Baclofen, Diazepam, Clonazepam, Trihexyphenidyl, Tetrabenazine, Gabapentin, Topiramate, Lamotrigine, Amitriptyline.drug
Drugs were used either singly or in combination guided by clinical findings and investigations.